Exact Sciences Investor Relations Material
Latest events
Study Update
Exact Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Exact Sciences Corporation
Access all reports
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States. The company operates through its three business segments: Colorectal Cancer Screening, Breast Cancer Detection, and ColoPath Products. It offers Cologuard, a diagnostic colon test for preventing colorectal cancer;Virtual Colonoscopy, a colorectal cancer screening test that uses 5-10 minutes of transmission of images of the digestive tract to provide virtual visualization of intestines; Cologuard GI, which offers Cologuard to patients at a subsidized price; and Fecal DNA Test that is designed to screen patients at high risk for hereditary nonpolyposis colorectal cancers (Lynch syndrome) or people who are not candidates for Virtual Colonoscopy. Exact Sciences Corporation is based in Madison, Wisconsin.
Key slides for Exact Sciences Corporation
Corporate Presentation
Exact Sciences Corporation
Q2 2023
Exact Sciences Corporation
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States